| Literature DB >> 35203218 |
Mohammad Asadi1, Abdolhakim Toghdory1, Maryam Hatami2, Jalil Ghassemi Nejad3.
Abstract
This study was conducted to investigate the effect of milk supplemented with organic iron on performance, blood hematology, iron metabolism parameters, biochemical and immunological parameters in suckling lambs. Thirty-six newborn Dalagh lambs were randomly divided into three groups with 12 replications. The control group was fed with milk without organic iron. The other two groups were fed milk supplemented with 25 and 50 mg/d organic iron, respectively. During the experiment, increased daily weight gain and total body weight were observed in the iron-supplemented groups. An increase in the levels of red blood cell, hemoglobin, hematocrit, mean corpuscular hemoglobin, and mean corpuscular concentration in iron supplemented groups was indicated. Consumption of organic iron caused a significant decrease in plasma copper concentration. Total antioxidant status level was lower, but levels of glutathione peroxidase, superoxide dismutase, and catalase were higher in iron supplemented groups. In organic iron supplemented groups, insulin and thyroid hormones levels were significantly increased, and glucose level was significantly decreased. In organic iron supplemented groups, alkaline phosphatase level significantly increased, and aminotransferase level significantly decreased. Overall, the use of organic iron in the milk improved the performance and health in suckling lambs, and since a lower level of supplementation is naturally preferable, supplementation of milk with 25 mg/d organic iron is recommended.Entities:
Keywords: antioxidants; hematology; organic iron; suckling lambs; thyroid hormones; weight gain
Year: 2022 PMID: 35203218 PMCID: PMC8868252 DOI: 10.3390/ani12040510
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
The effect of organic iron supplementation on suckling lambs.
| Item | Treatment 1 | SEM | |||
|---|---|---|---|---|---|
| Control | 25 mg/d | 50 mg/d | |||
| Initial weight (kg) | 4.33 | 4.28 | 4.40 | 0.148 | 0.1339 |
| Daily gain (1–10 d, g/d) | 202.56 b | 234.97 a | 238.85 a | 11.981 | 0.0319 |
| Body weight (10 d, kg) | 6.36 b | 6.63 a | 6.79 a | 0.249 | 0.0307 |
| Daily gain (11–20 d, g/d) | 191.82 b | 220.88 a | 228.26 a | 16.308 | 0.0118 |
| Body weight (20 d, kg) | 8.28 b | 8.84 a | 9.07 a | 0.447 | 0.0289 |
| Daily gain (21–30 d, g/d) | 168.57 b | 194.92 a | 190.85 a | 11.607 | 0.0074 |
| Body weight (30 d, kg) | 9.97 b | 10.79 a | 10.98 a | 0.675 | 0.0048 |
| Total daily gain (g/d) | 188.12 b | 217.09 a | 219.33 a | 8.179 | 0.0001 |
| Total body weight (kg) | 5.64 b | 6.51 a | 6.58 a | 0.248 | 0.0001 |
| Milk offered (1–30 d, g/d) | 639.80 | 657.02 | 670.33 | 32.147 | 0.0560 |
a,b Within a row, means without a common superscript differ significantly (p < 0.05). 1 Treatment = T1) milk without organic iron supplementation (control); T2) 25 mg/d organic iron supplementation, T3) 50 mg/d organic iron supplementation.
The effect of organic iron supplementation on hematological parameters.
| Item | Treatment 1 | SEM | |||
|---|---|---|---|---|---|
| Control | 25 mg/d | 50 mg/d | |||
| RBC 2, T/L | 8.80 b | 13.04 a | 12.95 a | 1.158 | 0.0015 |
| HGB 3, mmol/L | 6.49 b | 8.90 a | 9.12 a | 0.732 | 0.0271 |
| HCT 4, L/L | 0.24 b | 0.42 a | 0.45 a | 0.071 | 0.0148 |
| PLT 5, G/L | 841.28 | 819.11 | 824.70 | 42.09 | 0.2147 |
| MCV 6, fl | 29.51 | 31.29 | 31.02 | 2.087 | 0.2002 |
| MCH 7, fmol | 0.75 b | 0.84 a | 0.82 a | 0.251 | 0.0224 |
| MCHC 8, mmol/L | 18.58 b | 22.75 a | 23.12 a | 0.847 | 0.0225 |
| WBC 9, G/L | 9.00 | 8.75 | 8.66 | 0.738 | 0.5958 |
| NEUT 10, % | 9.20 | 9.50 | 9.25 | 0.278 | 0.6788 |
| EOS 11, % | 34.37 | 32.91 | 34.12 | 6.659 | 0.9803 |
| LYMPH 12, % | 2.26 | 2.29 | 2.29 | 0.062 | 0.3606 |
| MONO 13, % | 55.27 | 55.56 | 54.47 | 4.157 | 0.5773 |
a,b Within a row, means without a common superscript differ significantly (p < 0.05). 1 Treatment, T1) milk without organic iron supplementation (control); T2) 25 mg/d organic iron supplementation, T3) 50 mg/d organic iron supplementation. 2 RBC, red blood cells. 3 HGB. hemoglobin. 4 HCT, hematocrit. 5 PLT, platelet count test. 6 MCV, mean cell volume. 7 MCH, mean corpuscular hemoglobin. 8 MCHC, mean corpuscular hemoglobin concentration. 9 WBC, white blood cells. 10 NEUT, neutrophils. 11 EOS, eosinophils. 12 LYMPH, lymphocyte. 13 MONO, monocytes.
The effect of organic iron supplementation on iron metabolism parameters and other minerals.
| Item | Treatment 1 | SEM | |||
|---|---|---|---|---|---|
| Control | 25 mg/d | 50 mg/d | |||
| Iron, mol/L | 14.33 b | 16.28 a | 17.40 a | 0.748 | 0.0339 |
| UIBC 2, mol/L | 5.97 | 6.56 | 6.85 | 0.481 | 0.0549 |
| TIBC 3, mol/L | 18.41 | 18.00 | 17.78 | 0.554 | 0.0570 |
| Transferrin saturation, % | 69.82 b | 78.88 a | 79.26 a | 1.308 | 0.0018 |
| Transferrin, mg/mL | 2.98 b | 4.87 a | 5.01 a | 0.421 | 0.0001 |
| Calcium, ng/dL | 96.01 | 95.85 | 94.97 | 0.178 | 0.4128 |
| Zinc, ng/dL | 1.46 | 1.35 | 1.39 | 0.032 | 0.2100 |
| Phosphorus, ng/dL | 61.82 | 61.36 | 62.01 | 0.229 | 0.3485 |
| Copper, ng/dL | 0.81 a | 0.62 b | 0.59 b | 0.017 | 0.0001 |
a,b Within a row, means without a common superscript differ significantly (p < 0.05). 1 Treatment, T1) milk without organic iron supplementation (control); T2) 25 mg/d organic iron supplementation, T3) 50 mg/d organic iron supplementation. 2 UIBC, unsaturated iron binding capacity. 3 TIBC, total iron binding capacity.
The effect of organic iron supplementation on antioxidation status, biochemical and immunological parameters.
| Item | Treatment 1 | SEM | |||
|---|---|---|---|---|---|
| Control | 25 mg/d | 50 mg/d | |||
| TAS 2, mmol/L | 1.13 a | 0.92 b | 0.90 b | 0.148 | 0.0001 |
| GPx 3, nmol NADPH ox/mg | 5.64 b | 7.51 a | 7.58 a | 0.248 | 0.0001 |
| SOD 4, U/mg of proteins | 18.74 b | 31.24 a | 33.97 a | 2.104 | 0.0001 |
| CAT 5, U/mg of proteins | 0.49 b | 0.58 a | 0.62 a | 0.010 | 0.0001 |
| MDA 6, nmol/mL | 1.24 | 1.17 | 1.14 | 0.047 | 0.2356 |
| Insulin, ng/mL | 0.56 b | 0.67 a | 0.65 a | 0.081 | 0.0111 |
| Glucose, mmol/L | 5.96 a | 5.43 b | 5.49 b | 0.049 | 0.0217 |
| IGF-1 7, ng/mL | 48.82 | 50.88 | 47.26 | 1.372 | 0.0618 |
| TNF-α 8, pg/mL | 102.28 | 99.84 | 99.07 | 1.407 | 0.0689 |
| IgG 9, mg/mL | 13.30 | 12.56 | 12.98 | 0.498 | 0.5451 |
| IgM 10, mg/mL | 0.79 | 0.74 | 0.78 | 0.051 | 0.1874 |
| T3 11, nmol/L | 9.42 b | 10.74 a | 10.91 a | 0.192 | 0.0048 |
| T4 12, nmol/L | 100.16 b | 117.09 a | 120.39 a | 5.075 | 0.1241 |
| AST 13, u/L | 66.14 a | 54.12 b | 52.29 b | 1.487 | 0.0314 |
| ALT 14, u/L | 16.08 | 15.86 | 15.45 | 0.670 | 0.1121 |
| ALP 15, u/L | 197.29 b | 227.46 a | 223.13 a | 9.241 | 0.0001 |
| CPK 16, u/L | 61.01 | 57.24 | 59.16 | 2.377 | 0.1684 |
| LDH 17, u/L | 241.01 | 223.74 | 238.99 | 19.755 | 0.3448 |
a,b Within a row, means without a common superscript differ significantly (p < 0.05). 1 Treatment, T1) milk without organic iron supplementation (control); T2) 25 mg/d organic iron supplementation, T3) 50 mg/d organic iron supplementation. 2 TAS, total antioxidant status. 3 GPx, glutathione peroxidase. 4 SOD, superoxide dismutase. 5 CAT, catalase. 6 MDA, malondialdehyde. 7 IGF-1, insulin-like growth factor 1. 8 TNF-α, tumor necrosis factor. 9 IgG, immunoglobulin G. 10 IgM, immunoglobulin M. 11 T3, triiodothyronine. 12 T4, tetraiodothyronine. 13 AST, alkaline phosphatase. 14 ALT, alanine aminotransferase. 15 ALP, alkaline phosphatase. 16 CPK, creatine phosphokinase. 17 LDH, lactate dehydrogenase.